ChemFaces Product List

Catalog No.	Information
CFN95272	Peucenidin
CFN95271	Quercetin-3'-glucoside
CFN95270	Aegineoside
CFN95269	2-Methoxy-1,4-naphthoquinone
CFN95268	Cannabisin B Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease. It induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cell.
CFN95267	Saucerneol Saucerneol has significant cardiovascular effects such as vasorelaxant and negative inotropic actions.
CFN95266	Bidenoside C Bidenoside C may have hepatoprotective activity.
CFN95265	N-trans-caffeoyltyramine N-trans-caffeoyltyramine is a novel and potent modulator of inflammatory responses.
CFN95264	N-trans-caffeoyloctopamine N-trans-Caffeoyltyramine has both arginase inhibitory property and antioxidant capacity.
CFN95263	Indolelactic acid Indolelactic acid is a phytochormone.
CFN95262	15-Deoxypulic acid Reference standards.
CFN95261	15-Methoxy-16-oxo-15,16H-strictic acid Reference standards.
CFN95260	Phyllanthusiin C Reference standards.
CFN95259	New compound 6 Reference standards.
CFN95258	New compound 5 Reference standards.
CFN95257	Vanillic acid glucoside Reference standards.
CFN95256	N1,N5,N10-(E)-tri-p-coumaroylspermidine N1,N5,N10-(E)-tri-p-coumaroylspermidine shows free radical-scavenging activity.
CFN95255	Safflospermidine A Safflospermidine A is a potential natural tyrosinase inhibitor,it shows high antityrosinase activity (IC50 of 13.8 μM）.
CFN95254	Safflospermidine B Safflospermidine B is a potential natural tyrosinase inhibitor, it shows high antityrosinase activity (IC50 of 31.8μM).
CFN95253	N1,N5,N10-(Z)-tri-p-coumaroylspermidine N1,N5,N10-(Z)-tri-p-coumaroylspermidine shows weak inhibition effect on [3H]-5-HT reuptake in rat brain synaptosomes.
CFN95252	Vaccarin E Reference standards.
CFN95251	Nortrachelogenin-5'-C-beta-glucoside Reference standards.
CFN95250	(R)-O-isobutyroyllomatin (R)-O-isobutyroyllomatin shows significant dose-dependent protection against oxidative stress, it also exhibits cell proliferative effects.
CFN95249	Vicinin 2 Reference standards.
CFN95248	Quasipanaxatriol Quasipanaxatriol can greatly enhance the cytotoxicity of the anti-cancer drugs in P388/ADM cells.
CFN95247	Chamigrenol Chamigrenol is a promising candidate for the development of potent Na+/K+ ATPase inhibitors and antimicrobial agents. It inhibited the activities of Na+/K+-ATPase, with the IC50 value of 15.9 ± 0.54 μg/mL.
CFN95246	(-)-Cadin-4,10(15)-dien-11-oic acid Reference standards.
CFN95245	Sphenanlignan Reference standards.
CFN95244	Henricine Reference standards.
CFN95243	Neoarctin B Reference standards.
CFN95242	Lappaol B Reference standards.
CFN91840	(+)-Mediresinol Di-O-beta-D-glucopyranoside Reference standards.
CFN91841	Sibiricose A1 The sibiricosee A1, the sibiricose A5 and the tenuifoliside A have a better treatment function for tristimania caused by various reasons the sibiricose A5 and the tenuifoliside A have a certain protecting function for PC 12 cells damaged by glutamic acid and the sibiricosee A1, the sibiricose A5 and the tenuifoliside A all can shorten the tail-hanging resting time and the swim resting time of a mouse.
CFN91844	Regaloside B Regaloside B can inhibit the expression of iNOS and COX-2. Regaloside B has anti-inflammatory activity.
CFN91852	Regaloside A Regaloside A has anti-inflammatory activity.
CFN95241	Polygalacin D2 Polygalacin D2 may have antimicrobial activity.
CFN95240	Platycogenin A Reference standards.
CFN95239	Gypenoside XIII Reference standards.
CFN95238	3-Acetyl-ginsenoside F1 Reference standards.
CFN70479	Apioline Reference standards.
CFN70466	Manassantin B Manassantin B is a potent inhibitor of NF-κB activation by the suppression of transciptional activity of RelA/p65 subunit of NF-κB. It also possesses anti-EBV lytic replication activity. Manassantin B inhibits interleukin-6-induced signal transducer and activator of transcription 3 activation in Hep3B cells, it has potential as a potent anti-inflammatory drug for use in pathological processes such as sepsis or acute lung injury. Manassantin B exerts antifibrotic activity in HSC-T6 cells, in part, via inhibition of cell proliferation and decrease of collagen production.
CFN70401	2',4'-Dihydroxydihydrochalcone 2',4'-Dihydroxydihydrochalcone has cytotoxic, and anti-inflammatory activities.
CFN70398	Picein Total phenolic glycosides, fragilin, Picein, salicortin, tremulacin, and tremuloidin all correlated positively with shoot length in glasshouse plants on a carbon-biased balance, and male willows had generally lower levels of phenolic glycosides than females.
CFN70356	Cupressuflavone Cupressuflavone has hepatoprotective, analgesic and anti‐inflammatory effects. Cupressuflavone could exert a beneficial effect against oxidative stress by enhancing the antioxidant defense status, reducing lipid peroxidation, and protecting against the pathological changes induced by CCl4 in the liver and kidney tissues.
CFN70348	Caffeoyl alcohol Reference standards.
CFN70335	Quercetin 3-rutinoside 7-glucoside (Morkotin A) Reference standards.
CFN70333	Quercetin 3,4'-diglucoside Quercetin 3,4'-diglucoside possesses antioxidant activities.
CFN70318	Peltatoside Peltatoside has antinociceptive and antioxidative effects, it is capable of inducing analgesia through the activation of peripheral CB1 receptors, involving endocannabinoids in this process.
CFN70314	Cimicifugic acid F Cimicifugic acid F has antioxidant activity. Cimicifugic acid F shows inhibition of neutrophil elastase activity with an IC50 of 18 mumol/L. It also shows strong hyaluronidase inhibitory activity.
CFN70309	11-Oxomogroside IIIE Reference standards.

Previous 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next